AstraZeneca Vaccine’s Woes in Europe Aren’t Hurting Its Appeal Elsewhere

In the European Union, vaccine skepticism, contradictory statements by governments and reports of adverse reactions have eroded trust in the shot developed by AstraZeneca and University of Oxford, delaying an inoculation campaign that was already proceeding at a glacial pace.


Leave a Reply